Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $5.0M | 38 | 99.2% |
| Consulting Fee | $31,645 | 13 | 0.6% |
| Travel and Lodging | $4,983 | 14 | 0.1% |
| Honoraria | $4,500 | 5 | 0.1% |
| Unspecified | $1,256 | 2 | 0.0% |
| Food and Beverage | $752.58 | 12 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| DePuy Synthes Products, Inc. | $5.1M | 59 | $0 (2024) |
| Musculoskeletal Transplant Foundation Inc. | $6,757 | 11 | $0 (2021) |
| Amgen Inc. | $3,876 | 4 | $0 (2024) |
| Flexion Therapeutics, Inc. | $3,750 | 1 | $0 (2018) |
| Heron Therapeutics, Inc. | $2,074 | 2 | $0 (2017) |
| Baxter Healthcare | $1,164 | 2 | $0 (2022) |
| KCI USA, Inc | $600.00 | 1 | $0 (2018) |
| Zimmer Biomet Holdings, Inc. | $144.36 | 1 | $0 (2022) |
| MY01 Inc. | $120.53 | 1 | $0 (2024) |
| Total Joint Orthopedics, Inc. | $83.76 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $632,271 | 7 | DePuy Synthes Products, Inc. ($630,894) |
| 2023 | $726,933 | 5 | DePuy Synthes Products, Inc. ($726,933) |
| 2022 | $719,241 | 10 | DePuy Synthes Products, Inc. ($715,276) |
| 2021 | $747,730 | 7 | DePuy Synthes Products, Inc. ($746,230) |
| 2020 | $597,381 | 6 | DePuy Synthes Products, Inc. ($597,381) |
| 2019 | $689,794 | 24 | DePuy Synthes Products, Inc. ($687,986) |
| 2018 | $461,071 | 13 | DePuy Synthes Products LLC ($454,819) |
| 2017 | $510,651 | 12 | DePuy Synthes Products LLC ($506,946) |
All Payment Transactions
84 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $122,016.29 | General |
| Category: Ortho-Knee | ||||||
| 09/27/2024 | Amgen Inc. | EVENITY (Biological) | — | In-kind items and services | $334.28 | Research |
| Study: Romosozumab Promoted Bone Regeneration of Critical-Size Ulnar Defect Filled with Demineralized Bone • Category: Bone Health | ||||||
| 08/26/2024 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $245,141.86 | General |
| Category: Ortho-Knee | ||||||
| 08/09/2024 | MY01 Inc. | MY01 Continuous Compartmental Pressure Monitor (Device) | Food and Beverage | In-kind items and services | $120.53 | General |
| Category: Orthopedics | ||||||
| 05/30/2024 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $133,098.05 | General |
| Category: Ortho-Knee | ||||||
| 02/26/2024 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $130,638.18 | General |
| Category: Ortho-Knee | ||||||
| 02/02/2024 | Amgen Inc. | EVENITY (Biological) | — | In-kind items and services | $921.61 | Research |
| Study: Romosozumab Promoted Bone Regeneration of Critical-Size Ulnar Defect Filled with Demineralized Bone Matrix in a Non-Human Primate Model • Category: Bone Health | ||||||
| 11/23/2023 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $110,118.12 | General |
| Category: Ortho-Knee | ||||||
| 08/30/2023 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $382,094.79 | General |
| Category: Ortho-Knee | ||||||
| 07/03/2023 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $3,088.78 | General |
| Category: Ortho-Knee | ||||||
| 05/31/2023 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $116,490.69 | General |
| Category: Ortho-Knee | ||||||
| 03/02/2023 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $115,140.95 | General |
| Category: Ortho-Knee | ||||||
| 12/10/2022 | Medical Device Business Services, Inc. | ATTUNE (Device) | Food and Beverage | In-kind items and services | $36.86 | General |
| Category: Ortho-Knee | ||||||
| 11/24/2022 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $96,580.67 | General |
| Category: Ortho-Knee | ||||||
| 11/09/2022 | Baxter Healthcare | — | Travel and Lodging | In-kind items and services | $597.00 | General |
| 11/03/2022 | Baxter Healthcare | — | Travel and Lodging | In-kind items and services | $567.16 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/01/2022 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $206,029.57 | General |
| Category: Ortho-Knee | ||||||
| 08/22/2022 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $1,310.00 | General |
| Category: Bone Health | ||||||
| 08/22/2022 | Amgen Inc. | EVENITY (Biological) | Consulting Fee | Cash or cash equivalent | $1,310.00 | General |
| Category: Bone Health | ||||||
| 06/03/2022 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $203,430.03 | General |
| Category: Ortho-Knee | ||||||
| 03/25/2022 | Zimmer Biomet Holdings, Inc. | ROSA (Device) | Food and Beverage | In-kind items and services | $144.36 | General |
| Category: Knees | ||||||
| 03/03/2022 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $209,235.56 | General |
| Category: Ortho-Knee | ||||||
| 12/09/2021 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $179,812.69 | General |
| Category: Ortho-Knee | ||||||
| 12/01/2021 | Musculoskeletal Transplant Foundation Inc. | — | Honoraria | Cash or cash equivalent | $500.00 | General |
| 08/27/2021 | DePuy Synthes Products, Inc. | ATTUNE (Device) | Royalty or License | Cash or cash equivalent | $202,455.34 | General |
| Category: Ortho-Knee | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Romosozumab Promoted Bone Regeneration of Critical-Size Ulnar Defect Filled with Demineralized Bone Matrix in a Non-Human Primate Model | Amgen Inc. | $921.61 | 1 |
| Romosozumab Promoted Bone Regeneration of Critical-Size Ulnar Defect Filled with Demineralized Bone | Amgen Inc. | $334.28 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 396 | 468 | $408,910 | $65,372 |
| 2022 | 8 | 324 | 374 | $359,680 | $57,815 |
| 2021 | 7 | 339 | 404 | $396,735 | $66,232 |
| 2020 | 6 | 277 | 331 | $308,210 | $49,289 |
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2023 | 18 | 19 | $142,500 | $20,896 | 14.7% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2023 | 13 | 13 | $88,920 | $14,312 | 16.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 103 | 103 | $61,800 | $10,944 | 17.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 124 | 182 | $50,050 | $8,918 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 75 | 83 | $33,200 | $6,190 | 18.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 19 | 19 | $14,250 | $2,398 | 16.8% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2023 | 29 | 34 | $15,640 | $1,262 | 8.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 15 | 15 | $2,550 | $451.50 | 17.7% |
| 27447 | Replacement of knee joint, both sides of knee | Facility | 2022 | 18 | 18 | $135,000 | $20,063 | 14.9% |
| 27130 | Replacement of thigh bone and hip joint with prosthesis | Facility | 2022 | 13 | 13 | $88,920 | $14,521 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 82 | 82 | $49,200 | $8,658 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 115 | 156 | $42,900 | $7,681 | 17.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $14,250 | $2,814 | 19.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 25 | 29 | $11,600 | $2,262 | 19.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Facility | 2022 | 26 | 28 | $12,880 | $1,012 | 7.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 26 | 29 | $4,930 | $804.77 | 16.3% |
| 27130 | Replacement of thigh bone and hip joint prosthesis | Facility | 2021 | 20 | 21 | $143,640 | $23,851 | 16.6% |
| 27447 | Repair of knee joint, lower or upper part of joint, inside and outside area | Facility | 2021 | 15 | 16 | $111,360 | $18,150 | 16.3% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 101 | 101 | $60,600 | $10,916 | 18.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 139 | 191 | $52,525 | $10,126 | 19.3% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Facility | 2021 | 33 | 42 | $19,320 | $1,571 | 8.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 15 | 16 | $6,400 | $1,212 | 18.9% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Facility | 2021 | 16 | 17 | $2,890 | $406.38 | 14.1% |
| 27130 | Replacement of thigh bone and hip joint prosthesis | Facility | 2020 | 18 | 19 | $129,960 | $22,901 | 17.6% |
| 27447 | Repair of knee joint | Facility | 2020 | 12 | 12 | $83,520 | $14,498 | 17.4% |
About Dr. Jay Lieberman, MD
Dr. Jay Lieberman, MD is a Orthopaedic Surgery healthcare provider based in Los Angeles, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1316959935.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jay Lieberman, MD has received a total of $5.1M in payments from pharmaceutical and medical device companies, with $632,271 received in 2024. These payments were reported across 84 transactions from 11 companies. The most common payment nature is "Royalty or License" ($5.0M).
As a Medicare-enrolled provider, Lieberman has provided services to 1,336 Medicare beneficiaries, totaling 1,577 services with total Medicare billing of $238,708. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Practice Information
- Specialty Orthopaedic Surgery
- Location Los Angeles, CA
- Active Since 08/12/2006
- Last Updated 04/25/2017
- Taxonomy Code 207X00000X
- Entity Type Individual
- NPI Number 1316959935
Products in Payments
- ATTUNE (Device) $5.1M
- EVENITY (Biological) $3,876
- HTX-011 (Drug) $2,074
- PREVENA (Device) $600.00
- ROSA (Device) $144.36
- MY01 Continuous Compartmental Pressure Monitor (Device) $120.53
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Orthopaedic Surgery Doctors in Los Angeles
Kelly Vince, M.d, M.D
Orthopaedic Surgery — Payments: $11.1M
Mr. Thomas Schmalzried, Md Inc, MD INC
Orthopaedic Surgery — Payments: $6.3M
David Thordarson, M.d, M.D
Orthopaedic Surgery — Payments: $2.6M
David Skaggs, Md, MD
Orthopaedic Surgery — Payments: $2.4M
Dr. Edward Mcpherson, M.d, M.D
Orthopaedic Surgery — Payments: $1.6M
Dr. Justin Saliman, M.d, M.D
Orthopaedic Surgery — Payments: $1.1M